U.S. National Institute of Health www.cancer.gov National Cancer Institute
National Cancer institute
Office of Biorepositories and Biospecimen Research
Launch NCI Best Practices for Biospecimen

Sign Up For Updates     
Skip Header Links
Related Initiatives
Patient Corner
Biospecimen Research Network Symposium
Skip Left Links

NCI Alliance for Nanotechnology in Cancer

The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.

Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today's explosion in knowledge.

To learn more about the NCI Alliance for Nanotechnology in Cancer, visit http://nano.cancer.gov/.


Skip Footer Links